|
Baxter & Gilead Make Money From Swine Flu
Lee Brodie
CNBC
Tuesday, April 28, 2009
Stocks traded modestly lower by mid-day Monday. New details
about the swine flu gave health care and biotech names a boost
but dragged down the airlines, hotels and other travel &
leisure names.
Shares of Baxter, GlaxoSmithKline, Crucell and Gilead all made
gains on the potential that they could benefit from vaccines
and treatments.
Both Crucell and Gilead are names that I’m watching explains
Jon Najarian, because they both have a great deal of vaccine
exposure. But they’re also trading down to their session
lows, which suggests the panic may be abating.
Of course, there will be companies that make money from swine
flu -- it seems to me GlaxoSmithKline and Baxter are probably
good plays on that, Najarian adds.
Full
article here
|
INFOWARS:
BECAUSE THERE'S A WAR ON FOR YOUR MIND
|
|
